Alpha Teknova Inc (TKNO) - Total Assets
Based on the latest financial reports, Alpha Teknova Inc (TKNO) holds total assets worth $107.62 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See TKNO total equity for net asset value and shareholders' equity analysis.
Alpha Teknova Inc - Total Assets Trend (2019–2024)
This chart illustrates how Alpha Teknova Inc's total assets have evolved over time, based on quarterly financial data.
Alpha Teknova Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Alpha Teknova Inc's total assets of $107.62 Million consist of 36.0% current assets and 64.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.1% |
| Accounts Receivable | $4.31 Million | 3.6% |
| Inventory | $6.80 Million | 5.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $13.09 Million | 11.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Alpha Teknova Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see TKNO market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Alpha Teknova Inc's current assets represent 36.0% of total assets in 2024, an increase from 26.4% in 2019.
- Cash Position: Cash and equivalents constituted 3.1% of total assets in 2024, down from 7.1% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, a decrease from 63.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 11.0% of total assets.
Alpha Teknova Inc Competitors by Total Assets
Key competitors of Alpha Teknova Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.34 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥15.32 Billion |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
China | CN¥10.96 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
Alpha Teknova Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.27 | 4.73 | 4.14 |
| Quick Ratio | 4.27 | 3.94 | 3.24 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $29.63 Million | $36.21 Million | $12.45 Million |
Alpha Teknova Inc - Advanced Valuation Insights
This section examines the relationship between Alpha Teknova Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.49 |
| Latest Market Cap to Assets Ratio | 0.91 |
| Asset Growth Rate (YoY) | -7.6% |
| Total Assets | $118.77 Million |
| Market Capitalization | $108.66 Million USD |
Valuation Analysis
Near Book Valuation: The market values Alpha Teknova Inc's assets close to their book value (0.91x), suggesting investors view the company's assets at approximately fair value.
Significant Asset Reduction: Alpha Teknova Inc's assets decreased by 7.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Alpha Teknova Inc (2019–2024)
The table below shows the annual total assets of Alpha Teknova Inc from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $118.77 Million | -7.64% |
| 2023-12-31 | $128.59 Million | -15.55% |
| 2022-12-31 | $152.26 Million | -8.56% |
| 2021-12-31 | $166.51 Million | +164.68% |
| 2020-12-31 | $62.91 Million | +7.52% |
| 2019-12-31 | $58.51 Million | -- |
About Alpha Teknova Inc
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample m… Read more